Marketable Securities, Current in USD of Gossamer Bio, Inc. from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Gossamer Bio, Inc. quarterly Marketable Securities, Current history and change rate from Q4 2018 to Q3 2025.
  • Gossamer Bio, Inc. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $171M, a 42.6% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

Gossamer Bio, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $171M -$127M -42.6% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $187M -$81M -30.3% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $229M +$23.4M +11.4% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $248M -$15.9M -6.01% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $299M +$52.3M +21.2% 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $268M +$142M +114% 30 Jun 2024 10-Q 12 Aug 2024
Q1 2024 $206M +$68.9M +50.4% 31 Mar 2024 10-Q 07 May 2024
Q4 2023 $264M +$121M +83.9% 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 $246M +$95.4M +63.2% 30 Sep 2023 10-Q 09 Nov 2023
Q2 2023 $125M -$2.72M -2.13% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $137M +$3.9M +2.94% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $144M +$1.89M +1.33% 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 $151M -$1.64M -1.08% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $128M +$64.4M +101% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $133M +$119M +873% 31 Mar 2022 10-Q 10 May 2022
Q4 2021 $142M +$115M +434% 31 Dec 2021 10-K 17 Mar 2023
Q3 2021 $153M +$59.1M +63.3% 30 Sep 2021 10-Q 08 Nov 2021
Q2 2021 $63.5M -$50.8M -44.5% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $13.6M -$221M -94.2% 31 Mar 2021 10-Q 06 May 2021
Q4 2020 $26.6M -$240M -90% 31 Dec 2020 10-K 03 Mar 2022
Q3 2020 $93.4M -$222M -70.4% 30 Sep 2020 10-Q 10 Nov 2020
Q2 2020 $114M -$201M -63.8% 30 Jun 2020 10-Q 11 Aug 2020
Q1 2020 $235M -$75.6M -24.3% 31 Mar 2020 10-Q 12 May 2020
Q4 2019 $267M +$143M +116% 31 Dec 2019 10-K 26 Feb 2021
Q3 2019 $316M 30 Sep 2019 10-Q 12 Nov 2019
Q2 2019 $315M 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $310M 31 Mar 2019 10-Q 14 May 2019
Q4 2018 $123M 31 Dec 2018 10-K 24 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.